Search

Search Constraints

You searched for: Author/Creator Hirbe, Angela C.

Search Results

1. A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy. (September 2020)

3. An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. (September 2021)

5. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1‐associated malignant peripheral nerve sheath tumors. Issue 7 (22nd November 2016)

7. Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors. Issue 5 (3rd February 2023)

10. Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. (28th March 2022)